Remove Clinical Trials Remove Nurses Remove RNA
article thumbnail

?5 Things You Need to Know from Our Recent Gene Therapy Webinar

Worldwide Clinical Trials

The pandemic has had a lasting impact on the ability of sites to participate in trials, particularly in the US. We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. 5 Things You Need to Know from Our Recent Gene Therapy Webinar appeared first on Worldwide Clinical Trials.

article thumbnail

AI in pharma: Can it be used in DTC?

World of DTC Marketing

Measuring RNA, DNA quickly. Clinical Trials – Identifying the right candidate for the trial based on history and disease conditions, and additional attributes, overlaying with infection rates, demographics, and ethnicity to represent the most impacted. .

Doctor 164
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer Receives Positive CHMP Opinion for Conversion of PAXLOVID™ Conditional Marketing Authorization to Full Marketing Authorization in the European Union

Pfizer

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir. In preclinical studies, nirmatrelvir did not demonstrate evidence of mutagenic DNA interactions.

article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?

XTalks

In the ever-evolving landscape of pharmaceutical development, the complexity of early phase clinical trials is increasing. The company partners with small and large biopharma and medical device and diagnostic companies to optimize early clinical development through excellence in study design and execution.

article thumbnail

Pfizer to Provide U.S. Government with an Additional 3.7 Million Treatment Courses of PAXLOVID™ to Help Combat COVID-19

Pfizer

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. PAXLOVID may only be prescribed for an individual patient by physicians, advanced practice registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs.

Drugs 110
article thumbnail

U.S. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™

Pfizer

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. PAXLOVID may only be prescribed for an individual patient by physicians, advanced practice registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs.

Drugs 69
article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

The webinar also featured Kelsey Carter, MS, Clinical Trial Manager at Medpace who discussed the site, operational and regulatory challenges for neuroscience trials with direct CNS administration along with the strategies to mitigate these challenges. Figure 3 ).

Trials 83